# A Study of SHR-1314 in Healthy Subjects

> **NCT02934412** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** SHR-1314
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02934412
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-22
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-06-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934412, "A Study of SHR-1314 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02934412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*